Stable liposome aqueous suspension
AssigneeTaisho Pharmaceutical Co., Ltd.
InventorsKatsu Nakamori, Tsuguchika Yoshida, Ikuo Koyama, Toshiaki Nakajima, Mikiko Odawara
Life of this patent
Estimating the term…
Abstract
A liposome aqueous suspension containing taurine and benzalkonium chloride is disclosed. The liposome aqueous suspension undergoes no precipitation, agglomeration or change in particle size even when preserved at 40.degree. C. for 6 months and is inhibited from lyso-phospholipid formation.
Claims1
A liposome aqueous suspension containing taurine in the liposomes and the external aqueous phase, which contains 0.5 to 5.0% by weight of taurine based on the total amount of the liposome preparation and 0.05 to 20 mol %, based on the membrane component of the liposomes, of benzalkonium chloride in the membranes of the liposomes and the external aqueous phase.
Dependencies are inferred from the claim text.